CJ CheilJedang
South Korean food and bio conglomerate behind Bibigo, plus a struggling lysine and biomaterials arm.
CJ CheilJedang is not going away, but its bio arm is losing to Chinese producers on cost while an antitrust case and cash strain play out through 2026.
CJ CheilJedang makes Korean food products like Bibigo that sell well overseas, plus animal feed ingredients like lysine. The lysine business is getting squeezed by cheaper Chinese competitors like Meihua and Fufeng, and the company is also being prosecuted for price fixing, which has scared away investors and forced it to stop selling off pieces. If the antitrust case results in huge fines or if the lysine losses get worse in the next year, the company could struggle to fund its growing food business, which is the only bright spot.
Seoul Central District Prosecutors' antitrust case ruling on CJ, Daesang, Samyang starch-sugar pricing. Large fines or executive convictions would show domestic pricing power collapsing under legal pressure.
CJ's July 2026 three-pillar reorg division assignments and any renewed Green Bio or CJ Selecta divestiture attempt. Would show whether cash strain is easing or forcing distressed asset sales.
- 2025 revenue: 27.34 trillion won, +0.4% YoY
- 2025 operating profit fell ~15% to 1.23 trillion won
- Overseas food sales ~6 trillion won, topped domestic first time
- Antitrust prosecution and rising fines from starch-sugar cartel case.
- Bio segment margin erosion from Chinese lysine competition, 3 straight quarterly declines.
- Cash liquidity strain forced withdrawal of Green Bio and CJ Selecta divestitures.
- Domestic food market slump and standalone revenue decline.
| Rival | Direction | Evidence |
|---|---|---|
| Chinese lysine producers (Meihua, Fufeng, Global Bio-chem) | gaining on | Undercutting CJ on cost; bio margins declined 3 straight quarters through Q1 2026 |
| Daesang, Sajo CPK, Samyang | contesting | Co-fined 747.6B won July 2026 for starch-sugar price-fixing alongside CJ |
| Ajinomoto | contesting | Reported ~8% global lysine share vs CJ's ~7% per April 2026 market report (vendor-claimed estimate) |
- Is CJ CheilJedang profitable in 2025?
- Yes but shrinking: consolidated 2025 revenue was 27.34 trillion won (+0.4% YoY) while operating profit fell about 15% to 1.23 trillion won, as reported February 9, 2026, pressured by bio margin erosion and domestic food slump.
- Who owns CJ CheilJedang?
- CJ CheilJedang is a publicly traded subsidiary of South Korea's CJ Group, listed on the Korea Exchange as KRX:097950 (plus preferred shares 097955). It traces to 1953 as Samsung's first manufacturing business, spun off in the 1990s and renamed in 2007.
- Is CJ CheilJedang cutting jobs?
- Its Korea domestic food division headcount fell 3.4% YoY to 6,894 employees at end-2025, and the company is cutting over 4,000 SKUs to reduce fixed costs, per reporting dated April 4, 2026, even as global headcount grew modestly overseas.
- Could AI replace CJ CheilJedang's business?
- Unlikely; physical food manufacturing and fermentation are hard for AI to replace. CJ itself is deploying AI internally in bio-fermentation, claiming a 10% production capacity increase in some lines as of April 2025, as an efficiency tool rather than a threat to its core business.
- Who is CJ CheilJedang's biggest competitor?
- In lysine/amino acids, Chinese producers Meihua, Fufeng and Global Bio-chem are undercutting CJ on cost, contributing to three straight quarterly bio margin declines through Q1 2026. Domestically, Daesang and Samyang co-defend a starch-sugar oligopoly now under antitrust fire.
- Is CJ CheilJedang involved in a price-fixing scandal?
- Yes. Korea's Fair Trade Commission fined CJ CheilJedang and three rivals a combined 747.6 billion won on July 7, 2026 for an 8-year starch-sugar collusion scheme (2017-2025); CJ executives were among 22 individuals indicted in April 2026.
- 2026-07-07FTC fines CJ and 3 rivals 747.6B won for starch-sugar price-fixing; CJ portion ~120B won
- 2026-07-01Reorganizes into Lifestyle Foods, Technology Materials, Core Materials divisions
- 2026-06-29Launches Bibigo gim bugak seaweed snacks after ~30% CAGR 2023-2025
- 2026-05-11Q1 2026 revenue rises 6% YoY to 7.11 trillion won
- 2026-04-23Seoul prosecutors indict 22 individuals including CJ executives over cartel
- 2026-04-04Announces 4,000+ SKU cuts; domestic food headcount down 3.4% to 6,894
- 2026-02-09Reports 2025 consolidated revenue 27.34T won, operating profit down ~15%
- 2025-10-01Sells CJ Feed&Care livestock unit to Royal De Heus
- 2025-05-13Withdraws Green Bio and CJ Selecta sales as cash falls 84.7% YoY
- 2025-04-03Announces AI integration into biofoundry fermentation processes
- CJ's overseas food sales top domestic for first time (2026-02-09)
- CJ CheilJedang Operating Profit Falls 15.2% Amid Domestic, Bio Struggles (2026-02-09)
- 097950) Earnings Call Transcripts (2026-05-11)
- CJ Cheiljedang (KRX) (2026-07-02)
- CJ CheilJedang launches Bibigo gim bugak to fuel K-snack growth (2026-06-29)
- CJ CheilJedang Launches Spiciest Bibigo Kimchi in Thailand (2026-07-01)
- CJ CheilJedang reorganizes, sells livestock feed unit to Dutch company (2025-10-01)
- CJ CheilJedang withdraws major sales amid funding difficulties and tariff negotiations (2025-05-13)
- CJ CheilJedang Scraps Food-Bio Structure for Profit-Focused Three-Unit Overhaul (2026-07-01)
- Korea food giants cut jobs amid slump, curb hiring and pivot overseas (2026-04-04)
- Korea food giants cut jobs amid slump, curb hiring and pivot overseas (2026-04-04)
- CJ CheilJedang Number of Employees 2026 (2026-06-29)